As of 10:30 AM on the 15th, Celltrion is trading at 318,000 KRW, down 1.85% from the previous day. This represents a 10.61% increase compared to June 18. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have net sold 46,952 shares of Celltrion, while institutions have net bought 10,000 shares, according to provisional data. Over the past five days, individual investors have net bought 95,845 shares, whereas foreigners and institutions have net sold 67,787 shares and 55,608 shares, respectively.

On July 10, Celltrion was in the spotlight in the market for "rising due to a contract for contract manufacturing of a migraine treatment worth 115.6 billion KRW."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing